Destruction of mesenchymal stroma by CD8+ T-sEVs reduced invasion and metastasis of transplantable melanoma (B16F10), breast cancer (4T1) and sarcoma (CMS5m) tumours, in subcutaneous and metastatic mouse models [89]. This evidence concerns the gene CD8A and breast carcinoma.